Pharming Group NV (Pharming) is a research-based biopharmaceutical company and is focused on developing innovative therapeutics for significant medical needs. The company's lead product, proprietary technology and focus on R&D are its key strengths. However, cost inefficiency burden can be cause of concern for the company. The growth potential in strong pipeline products, changing demographics and new product approval including orphan drug designation are the opportunities for the company. However, uncertain R&D outcomes, government regulations, and competition and technological changes could have an adverse effect on the company's results of operations and financial performance.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer